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Mammalian counterparts of the yeast SRB/MED
transcriptional ‘mediator’ complex have recently been
identified. These complexes define a common cofactor
requirement for diverse transcriptional activators and
underscore the conserved nature of the transcriptional
machinery among eukaryotic organisms. 
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The transcription of protein-encoding genes in eukaryotic
cells requires RNA polymerase II and a set of general
transcription factors that include the TATA-binding protein
(TBP), TFIIB, TFIIE, TFIIF and TFIIH (reviewed in
[1]). These factors assemble at the core promoter and are
sufficient for accurate transcription initiation in vitro. Tran-
scriptional activators — which bind sequence-specific
enhancer elements located upstream of the core promoter
— stimulate the rate of transcription in response to physio-
logical or developmental stimuli. A third class of transcrip-
tion factors, known as coactivators or ‘mediators’, facilitate
the interaction between the sequence-specific activators
and the general RNA polymerase II machinery.
The first coactivators to be identified were the TBP-
associated factors (TAFs) — the non-TBP subunits of
general transcription factor TFIID. Whereas TBP is
sufficient for basal transcription in vitro, TFIID is
required for activated transcription in metazoan systems.
Interestingly, however, TAFs are not required for
activation in yeast cell-free systems, despite the presence
of TFIID in yeast. Instead, a mediator complex, referred
to here as SRB/MED, was identified on the basis of its
requirement for activation in vitro (reviewed in [2]).
SRB/MED comprises a subset of SRB proteins, identified
genetically as suppressors of truncations of the carboxy-
terminal repeat domain of the largest subunit of RNA
polymerase II, a novel set of proteins denoted MEDs, and
several polypeptides identified as either positive or nega-
tive effectors of transcription (reviewed in [3]). 
Another form of the SRB/MED complex was independently
identified as a component of a yeast RNA polymerase II
holoenzyme complex. The two SRB/MED complexes are
nearly identical, although a notable difference is the
absence of Srb8–Srb11 in the functionally-defined media-
tor complex. Interestingly, these SRB proteins were ini-
tially identified in genetic screens as negative effectors of
transcription. The structural differences between the two
complexes can then be explained by the different purifi-
cation strategies. Whereas mediator was isolated based on
its requirement for activation, the holoenzyme was ini-
tially purified independently of any functional require-
ment. This is an important difference, because it implies
the existence of functionally distinct SRB/MED subcom-
plexes (reviewed in [3]). Indeed, recent results [4] have
confirmed the modular nature of the yeast SRB/MED
complex and demonstrated that specific functions can be
attributed to each subcomplex (Figure 1).
Human homologs of SRB and MED proteins have been
identified, raising the possibility that SRB/MED
complexes also function in higher organisms. Affinity
purification of human Srb10 — also known as Cdk8 —
yielded a multisubunit complex, designated NAT, that
includes homologs of several SRB/MED components but
is devoid of RNA polymerase II [5]. However, NAT
functions as a general repressor of activated transcription,
rather than as a coactivator. NAT catalyzes phosphoryla-
tion of the RNA polymerase II carboxy-terminal repeat
domain, but in contrast to TFIIH, it does so prior to
assembly of the preinitiation complex. The same temporal
specificity has been defined for the yeast Srb10–Srb11
heterodimer [6], which is likely to account for the repres-
sive effects of both complexes on transcription.
Other complexes that include SRB and MED proteins
have been identified independently in human and mouse
cells [7,8]. The SMCC complex was affinity purified from
human cells expressing epitope-tagged SRB proteins and is
structurally similar to NAT. In contrast to NAT, however,
SMCC also mediates transcriptional activation, albeit in a
manner dependent upon another coactivator, PC4 [7,9]. A
mouse complex, mMED, that includes homologs of yeast
SRB/MED proteins has also been identified. mMED was
purified by conventional chromatography and contains a
protein similar to a mitogen-activated protein (MAP)
kinase, suggesting that SRB/MED complexes might be ter-
minal components of signal transduction pathways [8]. 
The identification of the NAT, SMCC and mMED
complexes established the existence of SRB/MED-like
complexes in mammalian cells. But what is the range of
activators (or repressors) whose activities are mediated by
these complexes? Recent studies have linked specific
activator proteins to their cognate coactivator complexes.
The TRAP and DRIP complexes were identified as
cofactors that mediate ligand-dependent activation by the
thyroid hormone receptor and the vitamin D3 receptor,
respectively [10,11]. Another SRB/MED complex,
denoted human mediator (hMED), was identified as a
cofactor for multiple activators, including E1A, VP16 and
Elk1 [12]. Further characterization of SMCC showed that
it acts as a cofactor of activation by thyroid hormone recep-
tor, VP16 and p53 [9]. All of these complexes share
common subunits and they are probably identical. Thus, a
broad range of activators stimulate transcription through
the same, or related, SRB/MED complexes.
A mammalian SRB/MED complex distinct from those
described above was identified as a mediator of Sp1
activation [13]. This complex, denoted CRSP, appears to
be a subcomplex of the larger SRB/MED complex,
suggesting that different SRB/MED complexes can be
assembled from a subset of SRB/MED components to
meet the needs of specific activators. This scenario is
comparable to the two SRB/MED complexes identified in
yeast, only one of which includes the Srb8–Srb11 subcom-
plex. The modular nature of SRB/MED complexes is also
suggested by genome-wide analysis of yeast srb and med
mutations, some of which cause global transcriptional
defects, whereas others affect expression of only a subset
of genes [14].
These studies investigated the cofactor requirements for
individual activators. Many genes, however, are regulated
by multiple enhancer elements that bind distinct activa-
tors. Furthermore, multiple activators often act synergisti-
cally to stimulate transcription. How does this complexity
affect coactivator requirements? This issue was recently
addressed in the case of cooperative activation by Sp1 and
the sterol-regulated factor SREBP-1a at the promoter of
the gene for the low-density lipoprotein receptor [15]. A
multisubunit coactivator complex that acts in a chromatin-
dependent manner on this promoter was identified. This
cofactor, designated ARC, is not specific for SREBP-1a
and Sp1, but also mediates activation by VP16 and NF-κB
[16]. Moreover, ARC turns out to be identical to
TRAP/DRIP/SMCC [9,11,16]. Thus, a single coactivator
can mediate synergistic activation, presumably by provid-
ing binding sites for multiple activators (Figure 1).
How do the TAFs fit into this picture of coactivation
mediated by SRB/MED complexes? As noted above, the
yeast SRB/MED complex mediates activation in a TAF-
independent manner. Yet in mammalian systems, TAFs
appeared to be required coactivators that act in concert
with other coactivators. This principle was recently chal-
lenged by the observation that the thyroid hormone recep-
tor can stimulate transcription on naked DNA templates
in a TRAP-dependent, TAF-independent manner [10].
This result not only shows that TAFs can be dispensable
for activation in mammalian systems, but indicates the
functional redundancy that exists among coactivator com-
plexes. Genetic analysis of coactivator requirements in
yeast led to a similar conclusion [17]. 
The findings on mammalian SRB/MED coactivator
complexes underscore the conserved nature of the RNA
polymerase II transcriptional machinery among eukaryotes.
Nevertheless, the mechanism by which these factors affect
transcription remains poorly defined. The yeast SRB/MED
complex is tightly associated with RNA polymerase II and
acts, at least in part, through the latter’s carboxy-terminal
repeat domain. The mammalian SRB/MED complexes
also interact with RNA polymerase II, but this interaction
occurs independently of the carboxy-terminal repeat
domain for both NAT and SMCC [5,7]. The ARC and
DRIP complexes are reported to function in a chromatin-
dependent manner, whereas CRSP, SMCC and hMED
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Figure 1
Transcriptional activation. Activator proteins —
A1, A2, A3 — bind to cognate enhancer
elements and interact directly with
coactivators and/or components of the core
transcriptional machinery, including RNA
polymerase II and the general transcription
factors (GTFs). Coactivators shown here
include SWI/SNF (chromatin remodeling
complex), SAGA (histone acetyltransferase
complex), SRB/MED (mediator) and the TAF
subunits of TFIID. The modular nature of the
SRB/MED complex is highlighted by labeling
the Srb4, Srb10, Med7 and Rgr1
subcomplexes, each of which includes several
polypeptides [3,4]. SRB/MED interacts
directly with RNA polymerase II through the
latter’s carboxy-terminal repeat domain to form
a holoenzyme complex in yeast [3];
mammalian SRB/MED complexes also
interact with RNA polymerase II, but
independently of the carboxy-terminal repeat
domain [5,7]. Many activators stimulate
transcription by recruiting TBP to the core
promoter, a process that occurs
synergistically with other core factors,
including RNA polymerase II, TFIIB and the
Srb4 component of SRB/MED [21,22].
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mediate activation on naked DNA templates. This distinc-
tion might, however, reflect differences in the assay condi-
tions, rather than real functional differences among the
complexes. Regardless, these issues highlight our nascent
understanding of SRB/MED functions. 
In addition to TAFs and SRB/MEDs, transcriptional
coactivators include chromatin remodeling factors and
histone acetyltransferases (Figure 1). These coactivators
work in a manner mechanistically distinct from
SRB/MEDs. The SWI/SNF chromatin remodeling
complex and the SAGA histone acetyltransferase complex
are both required for activation of the HO gene in yeast.
The assembly of these factors at the HO promoter was
recently investigated by DNA crosslinking and immuno-
precipitation analyses [18,19]. The promoter-specific tran-
scription factor Swi5 initiates activation by recruiting
SWI/SNF, which in turn recruits SAGA. The activities of
these two coactivators are essential for recruitment of
another sequence-specific factor, Swi4–Swi6, which pre-
sumably facilitates assembly of the preinitiation complex.
These results define the temporal relationship among
factors affecting HO expression. An earlier report [20] that
the SWI/SNF complex is a component of the yeast RNA
polymerase II holoenzyme also raises the interesting
possibility that Swi5 recruits the holoenzyme, which in
turn recruits SAGA.
DNA crosslinking and immunoprecipitation experiments
have also been used to study assembly of the transcription
preinitiation complex. Two related studies [21,22] investi-
gated the requirements for TBP occupancy of promoter
DNA in yeast. A general correlation was found between
TBP binding and transcriptional activity, consistent with
the premise that activators stimulate TBP recruitment to
promoter DNA. TBP recruitment was, however, depen-
dent upon additional factors, including RNA polymerase
II, TFIIB and Srb4. These results directly demonstrate
that activators can stimulate assembly of the transcription
preinitiation complex. Moreover, the observation of
activator-mediated, cooperative assembly of the preinitia-
tion complex challenges the notion that TBP recruitment
is the principal, rate-limiting step in transcription. 
The ability of diverse activators to act through common
SRB/MED coactivators simplifies our understanding of
activation. Nonetheless, SRB/MED complexes are intri-
cate structures composed of multiple subunits with ill-
defined functions. Many fundamental questions remain
unanswered. Do the different SRB/MED complexes exist
as pre-assembled structures, or are they assembled de
novo in response to specific activators and repressors?
What accounts for the functional distinctions among
SRB/MED complexes in their response to unique activa-
tors and repressors? Most importantly, how do SRB/MED
complexes communicate with the core transcriptional
machinery to regulate transcription? The answers to these
questions will come from the powerful combination of
genetic and biochemical approaches, using both yeast and
mammalian systems. 
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